News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
The increasing number of cell and gene therapies in clinical development is evolving the supply chain into a ‘supply cycle,’ says TrakCel CEO, with service providers being called to maintain control under pressure.
As the pharmaceutical industry grows globally, the market for cold chain technology, solutions, and innovations is working to keep pace.
Revance Therapeutics says developing a Botox biosimilar is “challenging, but not impossible” in reply to AbbVie’s dismissal of the prospect of a copy of the blockbuster coming to market.
The European Medicines Agency (EMA) tells manufacturers that use fish peptone in fermentation to declare the ingredient.